Prominent urinary dysfunction and delayed antibody detection in patients with glial fibrillary acidic protein astrocytopathy: a case series analysis
Authors:
Open Access
- 2 January 2026
- journal article
- research article
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Abstract
Background: Glial fibrillary acidic protein astrocytopathy (GFAP-A) is a rare central nervous system (CNS) autoimmune disorder with highly heterogeneous presentations. This study aims to describe the clinical and diagnostic features in a Chinese case series. Methods: Six patients at a single tertiary center with positive GFAP antibody were included, the patients’ data were retrospectively analyzed. Results: The cohort included 3 males and 3 females, with a median age of 56 years (range 30–75). Prominent urinary dysfunction was observed in four patients (66.7%). Brain or spinal cord MRI abnormalities were present in only 50% (3/6) of patients. All patients exhibited CSF-specific oligoclonal bands and elevated indices of intrathecal IgG synthesis. A notable finding was the delayed detection of CSF GFAP antibody in five patients (83.3%), who tested negative at disease onset but turned positive upon follow-up testing weeks to months later. Conclusion: This case series underscores the high frequency of autonomic urinary dysfunction and the potential for delayed antibody detection in Chinese GFAP-A patients. These findings suggest that clinical suspicion should remain high even with initial negative antibody testing, warranting repeat CSF analysis in suspected cases to avoid diagnostic delay.Keywords
Funding Information
- Peking University First Hospital (2023IR07)
This publication has 15 references indexed in Scilit:
- Glial Fibrillary Acidic Protein Astrocytopathy Based on a Two‐Center Chinese Cohort StudyAnnals of Clinical and Translational Neurology, 2025
- Clinical course and long-term outcomes in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathyJournal of Neurology, 2025
- Glial Fibrillary Acidic Protein Astrocytopathy: Review of Pathogenesis, Imaging Features, and Radiographic MimicsAmerican Journal of Neuroradiology, 2024
- Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: A systematic review and meta‐analysisEuropean Journal of Neurology, 2024
- Rapidly progressive dementia: Extending the spectrum of GFAP‐astrocytopathies?Annals of Clinical and Translational Neurology, 2022
- Blood GFAP as an emerging biomarker in brain and spinal cord disordersNature Reviews Neurology, 2022
- Standardized Nomenclature for Modified Rankin Scale Global Disability Outcomes: Consensus Recommendations From Stroke Therapy Academic Industry Roundtable XIStroke, 2021
- From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer’s DiseaseJournal of Alzheimer’s Disease, 2018
- Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective studyEuropean Journal of Neurology, 2017
- Autoimmune Glial Fibrillary Acidic Protein AstrocytopathyJAMA Neurology, 2016